查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585600

生化試劑市場：按產品類型、最終用戶分類 - 全球預測 2025-2030

Biochemical Reagents Market by Product Type (Cell & Tissue Culture Reagents, Chromatography Reagents, Electrophoresis Reagents), End-user (Academics & Research, Contract Research Organizations (CROs), Diagnostic Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生化試劑市值為158.7億美元，預計2024年將達到168.5億美元，複合年成長率為6.48%，到2030年將達到246.4億美元。

生化試劑是生物科學研究和製造過程中促進化學反應所必需的多種物質。其定義為用於各種化學分析和實驗的物質，其範圍涵蓋製藥、生物技術和生命科學，並在診斷、藥物開發和基因工程中發揮重要作用。分子生物學和個人化醫療的加速發展強調了對生化試劑的需求，其中準確和高效的生化檢測至關重要。這些試劑可應用於 DNA序列測定、細胞培養和層析法等關鍵過程，最終用途包括製藥、實驗室、臨床診斷和學術。主要成長要素包括對創新藥物的需求快速成長、生物製藥領域的擴張以及生命科學領域研究支出的增加。此外，慢性病和感染疾病的日益普及增加了對利用生化試劑的更精確診斷解決方案的需求。新的商機在於生物資訊學和蛋白質組學，其中高度特異性試劑的開發可以徹底改變資料的準確性和有效性。抓住這些機會的研究包括試劑製造商和高科技公司之間的策略聯盟，以開發先進的研究工具。然而，該市場面臨嚴格的法律規範、先進試劑的高成本以及導致價格戰的競爭加劇等限制。此外，技術過時也是一個重大挑戰，因為快速進步可以很快地使現有試劑過時。創新應著重於人工智慧和機器學習的整合，以提高試劑的準確性和效用，特別是在合成生物學和個人化醫療領域。市場多元化且競爭激烈，在挑戰中利用創新和持續成長需要深入的研究和策略遠見。透過專注於可擴展、經濟高效和多功能試劑的合成，公司可以在這個不斷變化的環境中培養更大的適應性和彈性。

主要市場統計
基準年[2023] 158.7億美元
預測年份 [2024] 168.5億美元
預測年份 [2030] 246.4億美元
複合年成長率（%） 6.48%

市場動態：揭示快速發展的生化試劑市場的關鍵市場洞察

生化試劑市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大生化試劑在下一代基因定序和聚合酵素鏈鎖反應的應用
    • 世界慢性病的增加
    • 拓展生化試劑在醫療保健和生命科學領域的應用
  • 市場限制因素
    • 開發生化試劑的高成本
  • 市場機會
    • 政府和生物技術公司增加對生化試劑研發活動的承諾和資助
    • 增加幹細胞研究以評估藥物毒性
  • 市場挑戰
    • 生化試劑開發核准嚴格規定

波特五力：駕馭生化試劑市場的策略工具

波特的五力框架是了解生化試劑市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生化試劑市場的外部影響

外部宏觀環境因素對生化試劑市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生化試劑市場競爭狀況

生化試劑市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生化試劑市場供應商績效評估

FPNV定位矩陣是評估生化試劑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪生化試劑市場的成功之路

生化試劑市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大生化試劑在下一代基因定序和聚合酵素鏈鎖反應的應用
      • 全球慢性病發生率正在上升
      • 拓展生化試劑在醫療保健和生命科學領域的應用
    • 抑制因素
      • 開發生化試劑的高成本
    • 機會
      • 政府和生物技術公司增加對生化試劑研發活動的承諾和資助
      • 擴大幹細胞研究以評估藥物毒性
    • 任務
      • 生化試劑開發核准嚴格規定
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生化試劑市場：依產品類型

  • 細胞/組織培養試劑
  • 層析法試劑
  • 電泳試劑
  • 聚合酵素鏈鎖反應（PCR）試劑組

第7章生化試劑市場：依最終用戶分類

  • 學術與研究
  • 合約研究組織（CRO）
  • 診斷中心
  • 醫院
  • 製藥和生物技術公司

第8章 南北美洲生化試劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太生化試劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲生化試劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Alpha Teknova, Inc.
  • AquaPhoenix Scientific, LLC.
  • Becton, Dickinson and Company.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux, Inc.
  • Biotron Diagnostics Inc.
  • Danaher Corporation
  • ERBA Diagnostics Mannheim
  • Euroclone SpA
  • Genelinx International, Inc.
  • LI-COR, Inc., d/b/a LI-COR Biosciences
  • Lonza Group Ltd.
  • Merck KGaA
  • Promega Corporation
  • ProteoChem, Inc.
  • Quality Biological, Inc.
  • Revvity, Inc.
  • Siemens Healthineers AG
  • Sysmex Asia Pacific Pte Ltd.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Viagen Biotech, Inc.
  • Waters Corporation
Product Code: MRR-521BAA36E9F1

The Biochemical Reagents Market was valued at USD 15.87 billion in 2023, expected to reach USD 16.85 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 24.64 billion by 2030.

Biochemical reagents constitute a diverse array of substances essential for facilitating chemical reactions in bioscientific research and manufacturing processes. Defined as substances used in various chemical analyses and experiments, their scope extends across pharmaceuticals, biotechnology, and life sciences, playing a critical role in diagnostics, drug development, and genetic engineering. The necessity of biochemical reagents is underscored by the accelerating advancements in molecular biology and personalized medicine, where accurate and efficient biochemical assays are indispensable. These reagents find application in critical processes such as DNA sequencing, cell culture, and chromatography, with end-use spanning pharmaceuticals, research labs, clinical diagnostics, and academia. Key growth influences encompass the surging demand for innovative drugs, the expansion of biopharmaceutical sectors, and rising research funding in life sciences. Additionally, the increasing prevalence of chronic and infectious diseases drives the demand for more precise diagnostic solutions utilizing biochemical reagents. Emerging opportunities lie in bioinformatics and proteomics, where the development of high-specificity reagents could revolutionize data accuracy and efficacy. Recommendations to seize such opportunities include strategic partnerships between reagent manufacturers and tech companies for advanced research tools development. However, this market faces limitations like stringent regulatory frameworks, high costs of advanced reagents, and heightened competition leading to price wars. Additionally, technological obsolescence poses significant challenges, where rapid advancements can outdate existing reagents quickly. Innovation should focus on the integration of AI and machine learning to enhance reagent precision and utility, particularly within synthetic biology and personalized medicine sectors. The market reveals a diverse yet highly competitive nature, requiring robust research and strategic foresight to leverage innovation and sustain growth amidst challenges. By focusing on the synthesis of scalable, cost-effective, and multifunctional reagents, companies can foster greater adaptability and resilience in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 15.87 billion
Estimated Year [2024] USD 16.85 billion
Forecast Year [2030] USD 24.64 billion
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biochemical Reagents Market

The Biochemical Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
    • Rise in the incidences of chronic diseases globally
    • Expanding the application of biochemical reagents in the healthcare and life science sectors
  • Market Restraints
    • High cost associated with the development of biochemical reagents
  • Market Opportunities
    • Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
    • Growing stem cell research to assess the toxicity of medications
  • Market Challenges
    • Strict regulations for the approval of the development of biochemical reagents

Porter's Five Forces: A Strategic Tool for Navigating the Biochemical Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biochemical Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biochemical Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biochemical Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biochemical Reagents Market

A detailed market share analysis in the Biochemical Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biochemical Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biochemical Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biochemical Reagents Market

A strategic analysis of the Biochemical Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biochemical Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Teknova, Inc., AquaPhoenix Scientific, LLC., Becton, Dickinson and Company., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux, Inc., Biotron Diagnostics Inc., Danaher Corporation, ERBA Diagnostics Mannheim, Euroclone S.p.A., Genelinx International, Inc., LI-COR, Inc., d/b/a LI-COR Biosciences, Lonza Group Ltd., Merck KGaA, Promega Corporation, ProteoChem, Inc., Quality Biological, Inc., Revvity, Inc., Siemens Healthineers AG, Sysmex Asia Pacific Pte Ltd., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., Viagen Biotech, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biochemical Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cell & Tissue Culture Reagents, Chromatography Reagents, Electrophoresis Reagents, and Polymerase Chain Reaction (PCR) Reagent Kits.
  • Based on End-user, market is studied across Academics & Research, Contract Research Organizations (CROs), Diagnostic Centers, Hospitals, and Pharma & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
      • 5.1.1.2. Rise in the incidences of chronic diseases globally
      • 5.1.1.3. Expanding the application of biochemical reagents in the healthcare and life science sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of biochemical reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
      • 5.1.3.2. Growing stem cell research to assess the toxicity of medications
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations for the approval of the development of biochemical reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biochemical Reagents Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cell & Tissue Culture Reagents
  • 6.3. Chromatography Reagents
  • 6.4. Electrophoresis Reagents
  • 6.5. Polymerase Chain Reaction (PCR) Reagent Kits

7. Biochemical Reagents Market, by End-user

  • 7.1. Introduction
  • 7.2. Academics & Research
  • 7.3. Contract Research Organizations (CROs)
  • 7.4. Diagnostic Centers
  • 7.5. Hospitals
  • 7.6. Pharma & Biotech Companies

8. Americas Biochemical Reagents Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biochemical Reagents Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biochemical Reagents Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alpha Teknova, Inc.
  • 3. AquaPhoenix Scientific, LLC.
  • 4. Becton, Dickinson and Company.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Techne Corporation
  • 7. bioMerieux, Inc.
  • 8. Biotron Diagnostics Inc.
  • 9. Danaher Corporation
  • 10. ERBA Diagnostics Mannheim
  • 11. Euroclone S.p.A.
  • 12. Genelinx International, Inc.
  • 13. LI-COR, Inc., d/b/a LI-COR Biosciences
  • 14. Lonza Group Ltd.
  • 15. Merck KGaA
  • 16. Promega Corporation
  • 17. ProteoChem, Inc.
  • 18. Quality Biological, Inc.
  • 19. Revvity, Inc.
  • 20. Siemens Healthineers AG
  • 21. Sysmex Asia Pacific Pte Ltd.
  • 22. Takara Bio USA, Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Viagen Biotech, Inc.
  • 25. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. BIOCHEMICAL REAGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCHEMICAL REAGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOCHEMICAL REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOCHEMICAL REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCHEMICAL REAGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCHEMICAL REAGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CELL & TISSUE CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CHROMATOGRAPHY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY ELECTROPHORESIS REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR) REAGENT KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY ACADEMICS & RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. BIOCHEMICAL REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. BIOCHEMICAL REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023